Long-term electroacupuncture stimulation prevents osteoporosis in ovariectomised osteopaenic rats through multiple signalling pathways

Acupunct Med. 2018 Jun;36(3):176-182. doi: 10.1136/acupmed-2016-011268. Epub 2018 Apr 6.

Abstract

Background: The pathogenic mechanisms of postmenopausal osteoporosis (PMOP) development are complex and are related to multiple cellular signalling transduction pathways. The aim of this study was to compare the effects of electroacupuncture (EA) at GV4/GV6 versus BL20/BL23 on the bones in ovariectomised (OVX) rats to explore the pathways that mediate the effects of EA on bone.

Methods: Forty female Sprague-Dawley rats were allocated to one of four groups (n=10 rats each) that received sham surgery (Sham group), OVX surgery only (OVX group), OVX surgery plus EA at GV4/GV6 (GV group) and OVX surgery plus EA at BL20/BL23 (BL group). Bone turnover markers osteocalcin (OC) and tartrate-resistant acid phosphatase 5b (TRACP 5b) were measured in serum, and bone mineral density (BMD) of the lumbar vertebrae and histomorphology of the femur were evaluated. Moreover, the expression of osteoprotegerin (OPG) and receptor activator of nuclear factor-κB ligand (RANKL) was detected by ELISA. The expression of lipoprotein receptor-related protein (LRP) 5, β-catenin, runt-related transcription factor (Runx) 2 involving Wnt/β-catenin signalling and p38, c-Jun N-terminal kinase (JNK) and extracellular regulated protein kinases 1/2 involving mitogen-activated protein kinase signalling were determined by Western blotting.

Results: The two EA-treated groups demonstrated increased levels of OC and the BMD of lumbar vertebrae, decreased levels of TRACP 5b and improved bone microstructure in the femur, compared with the untreated OVX group (P<0.05). Histomorphology analysis showed that EA treatment significantly increased the values of the trabeculae (µm), trabecular area (%) and trabecular bone number (per mm) and reduced trabecular separation (mm), compared with the OVX group. In addition, the ratio of OPG to RANKL and LRP5, β-catenin and Runx2 expression were significantly upregulated, while the expression of phosphorylated (p)-p38 and p-JNK were downregulated in EA-treated groups compared with the OVX group.

Conclusion: EA attenuates PMOP and it appears that the mechanism involves the regulation of multiple targets and pathways.

Keywords: bone diseases; complementary medicine; electroacupuncture; pharmacology.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acupuncture Points
  • Animals
  • Bone Density
  • Core Binding Factor Alpha 1 Subunit / genetics
  • Core Binding Factor Alpha 1 Subunit / metabolism
  • Electroacupuncture*
  • Female
  • Humans
  • MAP Kinase Kinase 4 / genetics
  • MAP Kinase Kinase 4 / metabolism
  • Osteocalcin / genetics
  • Osteocalcin / metabolism
  • Osteoporosis, Postmenopausal / genetics
  • Osteoporosis, Postmenopausal / metabolism
  • Osteoporosis, Postmenopausal / physiopathology
  • Osteoporosis, Postmenopausal / prevention & control*
  • Osteoprotegerin / genetics
  • Osteoprotegerin / metabolism
  • Ovariectomy
  • RANK Ligand / genetics
  • RANK Ligand / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Signal Transduction*
  • Tartrate-Resistant Acid Phosphatase / genetics
  • Tartrate-Resistant Acid Phosphatase / metabolism

Substances

  • Core Binding Factor Alpha 1 Subunit
  • Osteoprotegerin
  • RANK Ligand
  • Runx2 protein, rat
  • Tnfrsf11b protein, rat
  • Osteocalcin
  • MAP Kinase Kinase 4
  • Tartrate-Resistant Acid Phosphatase